Last checked at 7 May 2021 08:32
AstraZeneca reports positive results in Phase 3 lung cancer drug trial
AstraZeneca reports positive results in Phase 3 lung cancer drug trial
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades16,417
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,050.00
Bid:
12,038.00
Ask:
12,040.00
Change:
-106.00 (-0.87%)
Spread:
2.00 (0.017%)
Open:
12,092.00
High:
12,178.00
Low:
12,010.00
Prev. Close:
12,156.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.7 May 2021 07:42
AstraZeneca's Imfinzi demonstrates benefit in combination with antibody
(Sharecast News) - AstraZeneca reported on Friday that 'Imfinzi' and tremelimumab with chemotherapy demonstrated an overall survival benefit in the 'POSEIDON' trial for first-line stage four non-small cell lung cancer, making it the first phase 3 trial to demonstrate an overall survival benefit with tremelimumab.
Read more7 May 2021 06:32
UK holidaymakers set to find out quarantine-free destinations Friday
UK holidaymakers set to find out quarantine-free destinations Friday
Read more6 May 2021 23:19
Under-40s in Britain to be offered alternative to AstraZeneca vaccine -newspapers
May 6 (Reuters) - People under the age of 40 in Britain will be offered an alternative to the Oxford/AstraZeneca COVID-19 vaccine following concerns of rare blood clots, The Daily Telegraph and The Independent newspapers reported on Thursday.The ...
Read more6 May 2021 18:08
UPDATE 1-Germany to allow AstraZeneca COVID-19 vaccine for all adults
(Adds detail)BERLIN, May 6 (Reuters) - Germany will allow AstraZeneca's COVID-19 vaccine to be administered to adults of all ages and aims to offer 12-18 year olds a vaccine by the end of August as it seeks to speed up its rollout, Health Minister...
Read more6 May 2021 16:54
Germany to allow AstraZeneca COVID-19 vaccine to all adults - minister
BERLIN, May 6 (Reuters) - Germany will allow AstraZeneca's COVID-19 vaccine to be given to adults of all ages, reversing a previous decision that restricted it to people who are over 60 years old, Health Minister Jens Spahn said on Thursday.Spahn ...
Read more6 May 2021 15:32
UK regulator says some evidence AstraZeneca clots occur more in women than men
LONDON, May 6 (Reuters) - Britain's medicine regulator on Thursday said there was some evidence that uncommon blood clots linked to AstraZeneca's COVID-19 vaccine occurred more in women than in men, adding that the difference in incidence was sma...
Read more6 May 2021 13:43
Thursday broker round-up
(Sharecast News) - National Grid: Berenberg upgrades to buy with a target price of 1,100p.
Read more6 May 2021 12:32
UPDATE 1-UK working with U.S., WTO on boosting COVID vaccine supply
(Adds detail)LONDON, May 6 (Reuters) - Britain is discussing ways of increasing production and supply of COVID-19 vaccines with the United States and World Trade Organization, a government spokesperson said on Thursday after Washington supported w...
Read more6 May 2021 12:09
LONDON MARKET MIDDAY: BoE expects strong UK growth in 2nd quarter
LONDON MARKET MIDDAY: BoE expects strong UK growth in 2nd quarter
Read more6 May 2021 12:03
EXPLAINER-COVID-19 vaccine patent waiver talks could still take months
By Philip BlenkinsopBRUSSELS, May 6 (Reuters) - President Joe Biden threw his support behind waiving intellectual property rights for COVID-19 vaccines in a sharp U.S. reversal, but it could take months for the World Trade Organization (WTO) to ha...
Read more6 May 2021 11:52
UK working with U.S., WTO on boosting COVID vaccine supply - spokesman
LONDON, May 6 (Reuters) - Britain is discussing ways of increasing production and supply of COVID-19 vaccines with the United States and World Trade Organization, a government spokesperson said on Thursday after Washington supported waiving their...
Read more6 May 2021 10:30
QUOTES-U.S. backs giving poorer countries access to COVID-19 vaccine patents
(Adds WHO chief)May 6 (Reuters) - U.S. President Joe Biden on Wednesday supported waiving intellectual property rights for COVID-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering pha...
Read more6 May 2021 10:30
QUOTES-U.S. backs giving poorer countries access to COVID-19 vaccine patents, reversing stance
(Adds material)May 6 (Reuters) - U.S. President Joe Biden on Wednesday supported waiving intellectual property rights for COVID-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering phar...
Read more6 May 2021 10:30
QUOTES-U.S. backs giving poorer countries access to COVID-19 vaccine patents
(Adds material)May 6 (Reuters) - U.S. President Joe Biden on Wednesday supported waiving intellectual property rights for COVID-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering phar...
Read more